Anal HPV Infection and Disease: A Model for Understanding All Things HPV
Joel Palefsky, M.D., C.M., F.R.C.P.(C) is Professor of Medicine in the Division of Infectious Diseases at the University of California San Francisco School of Medicine. His research interests center on the molecular pathogenesis, natural history, treatment and prevention of HPV-related disease, particularly in the setting of HIV infection. He is the founder and director of the world's first clinic devoted to prevention of anal cancer, the Anal Neoplasia Clinic Research and Education Center at the UCSF Cancer Center. He has pioneered diagnostic and treatment methods for anal intraepithelial neoplasia (AIN) and has been an advocate for screening and treatment of AIN in high-risk populations to prevent anal cancer.
Dr. Palefsky is the protocol chair of the NCI-supported ANal Cancer/HSIL Outcomes Research (ANCHOR) Study. He is the chair of the HPV Working Group of the U.S. National Cancer Institute-supported AIDS Malignancy Consortium. He is the founder and past president of the International Anal Neoplasia Society and past president of the International Papillomavirus Society. He is a member of the ASCI and AAP and is the author of over 350 publications.